More than 530 physicians, technologists, scientists, laboratory professionals, and medical experts from around the world gathered in New Orleans in January for the Society of Nuclear Medicine and Molecular Imaging’s Mid-Winter Meeting. The meeting, cosponsored by the American College of Nuclear Medicine and the Chinese Society of Nuclear Medicine (CSNM), offered attendees first-class education on current and emerging technical, preclinical, and clinical applications of nuclear medicine and molecular imaging.
“This year’s meeting covered topics that are generating a lot of interest in the field of nuclear medicine and molecular imaging, such as PET/MR, amyloid imaging, targeted radionuclide therapy, and regulations,” said Satoshi Minoshima, MD, PhD, chair of the Mid-Winter Meeting, Associate Chair of the SNMMI Scientific Program Committee.
Of particular interest was the course, “A Different Spin on Nuclear Imaging: The Role of PET/MRI in Molecular Imaging,” presented by SNMMI’s Center for Molecular Imaging Innovation and Translation and SNMMI’s PET Center of Excellence. “This was a very interesting seminar with cutting-edge technology,” said session attendee Daniel Mack, CNMT, of the Mayo Clinic. “Where will it go? It appears that it will be a much bigger challenge than PET/CT was years ago; extremely challenging.” The CT case review workshops were also very popular among attendees.
From a more global standpoint, the second Sino-American Nuclear Medicine Conference co-sponsored by the SNMMI and the CSNM was held in conjunction with the Mid-Winter Meeting. More than 100 attendees—including CSNM leaders, SNMMI leaders and members and young professionals from both China and the US—discussed the global challenges and opportunities in nuclear medicine and molecular imaging.
SNMMI’s next education event, the 2013 Annual Meeting, will be held June 8-12, in Vancouver, British Columbia, Canada. For more information on the 2013 Annual Meeting, please visit www.snmmi.org/am.
